These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 36920695)
1. Pseudotyped Viruses for Coronaviruses. Wang M; Nie J; Wang Y Adv Exp Med Biol; 2023; 1407():133-151. PubMed ID: 36920695 [TBL] [Abstract][Full Text] [Related]
2. Fully automated detection and differentiation of pandemic and endemic coronaviruses (NL63, 229E, HKU1, OC43 and SARS-CoV-2) on the hologic panther fusion. Cordes AK; Rehrauer WM; Accola MA; Wölk B; Hilfrich B; Heim A J Med Virol; 2021 Jul; 93(7):4438-4445. PubMed ID: 33350484 [TBL] [Abstract][Full Text] [Related]
3. Coronavirus Pseudotypes for All Circulating Human Coronaviruses for Quantification of Cross-Neutralizing Antibody Responses. Sampson AT; Heeney J; Cantoni D; Ferrari M; Sans MS; George C; Di Genova C; Mayora Neto M; Einhauser S; Asbach B; Wagner R; Baxendale H; Temperton N; Carnell G Viruses; 2021 Aug; 13(8):. PubMed ID: 34452443 [TBL] [Abstract][Full Text] [Related]
4. An overview on the seven pathogenic human coronaviruses. Kesheh MM; Hosseini P; Soltani S; Zandi M Rev Med Virol; 2022 Mar; 32(2):e2282. PubMed ID: 34339073 [TBL] [Abstract][Full Text] [Related]
5. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses. Lawrenz J; Xie Q; Zech F; Weil T; Seidel A; Krnavek D; van der Hoek L; Münch J; Müller JA; Kirchhoff F Clin Infect Dis; 2022 Aug; 75(1):e653-e661. PubMed ID: 35079775 [TBL] [Abstract][Full Text] [Related]
6. HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV. Milewska A; Chi Y; Szczepanski A; Barreto-Duran E; Dabrowska A; Botwina P; Obloza M; Liu K; Liu D; Guo X; Ge Y; Li J; Cui L; Ochman M; Urlik M; Rodziewicz-Motowidlo S; Zhu F; Szczubialka K; Nowakowska M; Pyrc K J Virol; 2021 Jan; 95(4):. PubMed ID: 33219167 [TBL] [Abstract][Full Text] [Related]
7. Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples. Shrwani K; Sharma R; Krishnan M; Jones T; Mayora-Neto M; Cantoni D; Temperton NJ; Dobson SL; Subramaniam K; McNamara PS; Cunliffe NA; Turtle L; Zhang Q J Infect Dis; 2021 Oct; 224(8):1305-1315. PubMed ID: 34161567 [TBL] [Abstract][Full Text] [Related]
8. The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study. Townsend JP; Hassler HB; Wang Z; Miura S; Singh J; Kumar S; Ruddle NH; Galvani AP; Dornburg A Lancet Microbe; 2021 Dec; 2(12):e666-e675. PubMed ID: 34632431 [TBL] [Abstract][Full Text] [Related]
9. Human and novel coronavirus infections in children: a review. Rajapakse N; Dixit D Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199 [TBL] [Abstract][Full Text] [Related]
10. Neutralizing and binding activities against SARS-CoV-1/2, MERS-CoV, and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan. Kubota-Koketsu R; Terada Y; Yunoki M; Sasaki T; Nakayama EE; Kamitani W; Shioda T Transfusion; 2021 Feb; 61(2):356-360. PubMed ID: 33104267 [TBL] [Abstract][Full Text] [Related]
11. Mechanistic insights into SARS-CoV-2 epidemic via revealing the features of SARS-CoV-2 coding proteins and host responses upon its infection. Qin S; Xia X; Shi X; Ji X; Ma F; Chen L Bioinformatics; 2021 Jan; 36(21):5133-5138. PubMed ID: 32805023 [TBL] [Abstract][Full Text] [Related]
13. Current Strategies of Antiviral Drug Discovery for COVID-19. Mei M; Tan X Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887 [TBL] [Abstract][Full Text] [Related]
14. Coronavirus HKU1 and other coronavirus infections in Hong Kong. Lau SK; Woo PC; Yip CC; Tse H; Tsoi HW; Cheng VC; Lee P; Tang BS; Cheung CH; Lee RA; So LY; Lau YL; Chan KH; Yuen KY J Clin Microbiol; 2006 Jun; 44(6):2063-71. PubMed ID: 16757599 [TBL] [Abstract][Full Text] [Related]
15. Evolutionary trajectory of SARS-CoV-2 and emerging variants. Singh J; Pandit P; McArthur AG; Banerjee A; Mossman K Virol J; 2021 Aug; 18(1):166. PubMed ID: 34389034 [TBL] [Abstract][Full Text] [Related]
16. More tools for our toolkit: The application of HEL-299 cells and dsRNA-nanoparticles to study human coronaviruses in vitro. Semple SL; Alkie TN; Jenik K; Warner BM; Tailor N; Kobasa D; DeWitte-Orr SJ Virus Res; 2022 Nov; 321():198925. PubMed ID: 36115551 [TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies constructed from COVID-19 convalescent memory B cells exhibit potent binding activity to MERS-CoV spike S2 subunit and other human coronaviruses. Peng Y; Liu Y; Hu Y; Chang F; Wu Q; Yang J; Chen J; Teng S; Zhang J; He R; Wei Y; Bostina M; Luo T; Liu W; Qu X; Li YP Front Immunol; 2022; 13():1056272. PubMed ID: 36618428 [TBL] [Abstract][Full Text] [Related]
18. Mouse models susceptible to HCoV-229E and HCoV-NL63 and cross protection from challenge with SARS-CoV-2. Liu D; Chen C; Chen D; Zhu A; Li F; Zhuang Z; Mok CKP; Dai J; Li X; Jin Y; Chen Z; Sun J; Wang Y; Li Y; Zhang Y; Wen L; Zhang Z; Zhuo J; Wang J; Ran W; Wang D; Zhang S; Tang Y; Li S; Lai X; Wei P; Yuan J; Chen F; Huang S; Sun F; Qian Z; Tan W; Zhao J; Peiris M; Zhao J Proc Natl Acad Sci U S A; 2023 Jan; 120(4):e2202820120. PubMed ID: 36652473 [TBL] [Abstract][Full Text] [Related]
19. The Flexible, Extended Coil of the PDZ-Binding Motif of the Three Deadly Human Coronavirus E Proteins Plays a Role in Pathogenicity. Schoeman D; Cloete R; Fielding BC Viruses; 2022 Aug; 14(8):. PubMed ID: 36016329 [TBL] [Abstract][Full Text] [Related]
20. Etiology and clinical characteristics of SARS-CoV-2 and other human coronaviruses among children in Zhejiang Province, China 2017-2019. Zhang Y; Su L; Chen Y; Yu S; Zhang D; Mao H; Fang L Virol J; 2021 Apr; 18(1):89. PubMed ID: 33931105 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]